{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:39:29Z","timestamp":1776904769786,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10072-017-2964-z","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T07:59:03Z","timestamp":1494316743000},"page":"1405-1413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Negative impact of high cumulative glucocorticoid dose on bone metabolism of patients with myasthenia gravis"],"prefix":"10.1007","volume":"38","author":[{"given":"Nayara Felicidade Tomaz","family":"Braz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia Pessoa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rica Leandro Marciano","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Santiago","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela Guimar\u00e3es","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ol\u00edvio Brito","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Lucio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"2964_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/WCO.0b013e32833cc968","volume":"23","author":"ME Farrugia","year":"2010","unstructured":"Farrugia ME, Vincent A (2010) Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol 23:489\u2013495","journal-title":"Curr Opin Neurol"},{"key":"2964_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11910-010-0151-1","volume":"11","author":"V Kumar","year":"2011","unstructured":"Kumar V, Kaminski HJ (2011) Treatment of myasthenia gravis. Curr Neurol Neurosci Rep 11:89\u201396","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2964_CR3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62:1515\u20131526","journal-title":"Arthritis Care Res"},{"key":"2964_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clineuro.2003.12.001","volume":"106","author":"N Wakata","year":"2004","unstructured":"Wakata N, Nemoto H, Sugimoto H (2004) Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. Clin Neurol Neurosurg 106:139\u2013141","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"2964_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00198-012-1970-5","volume":"24","author":"S Pouwels","year":"2012","unstructured":"Pouwels S, Boer A, Javaid MK, Jones DH, Verschuuren J, Cooper C, Leufkens HG, Vries F (2012) Fracture rate in patients with myasthenia gravis: the general practice research database. Osteoporos Int 24(2):467\u2013476","journal-title":"Osteoporos Int"},{"key":"2964_CR6","first-page":"1","volume":"10","author":"S Konno","year":"2015","unstructured":"Konno S, Suzuki S, Masuda M, Nagane Y, Tsuda E, Murai H, Imai T, Fujioka T, Suzuki N, Utsugisawa K (2015) Association between glucocorticoid-induced osteoporosis and myasthenia gravis: a cross-sectional study. PLoS One 10:1\u20137","journal-title":"PLoS One"},{"key":"2964_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1385\/JCD:7:4:359","volume":"7","author":"M Maricic","year":"2004","unstructured":"Maricic M, Gluck O (2004) Densitometry in glucocorticoid-induced osteoporosis. J Clin Densitom 7:359\u2013363","journal-title":"J Clin Densitom"},{"key":"2964_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","volume":"57","author":"L Gifre","year":"2013","unstructured":"Gifre L, Ruiz-Gasp\u00e0 S, Monegal A, Nomdedeu B, Filella X, Gua\u00f1abens N, Peris P (2013) Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover. Bone 57:272\u2013276","journal-title":"Bone"},{"key":"2964_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JG, Penn AS (2000) Myasthenia gravis. Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:1\u201314","journal-title":"Neurology"},{"key":"2964_CR10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","volume":"74","author":"TM Burns","year":"2010","unstructured":"Burns TM, Conaway M, Sanders DB (2010) The MG composite. A valid and reliable outcome measure for myasthenia gravis. Neurology 74:1434\u20131440","journal-title":"Neurology"},{"key":"2964_CR11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01623782","volume":"7","author":"JA Kanis","year":"1997","unstructured":"Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 7:390\u2013406","journal-title":"Osteoporos Int"},{"key":"2964_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000000561","volume":"83","author":"JH Yeh","year":"2014","unstructured":"Yeh JH, Chen HJ, Chen YK, Chiu HC, Kao CH (2014) Increased risk of osteoporosis in patients with myasthenia gravis. A population-based cohort study. Neurology 83:1\u20135","journal-title":"Neurology"},{"key":"2964_CR13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","volume":"132","author":"B Buehring","year":"2013","unstructured":"Buehring B, Viswanathan R, Binkley N, Busse W (2013) Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol 132:1019\u20131030","journal-title":"J Allergy Clin Immunol"},{"key":"2964_CR14","first-page":"569","volume":"52","author":"RMR Pereira","year":"2012","unstructured":"Pereira RMR, Carvalho JFC, Paula AP, Zerbini C, Domiciano DS, Gon\u00e7alves H, Danowski JS, Neto JFM, Mendon\u00e7a LMC, Bezerra MC, Terreri MT, Imamura M, Weingrill P, Plapler PG, Radominski S, Tourinho T, Szejnfeld VL, Andrada NC (2012) Diretrizes para preven\u00e7\u00e3o e tratamento da osteoporose induzida por glicocorticoide. Rev Bras Reumatol 52:569\u2013593","journal-title":"Rev Bras Reumatol"},{"key":"2964_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","volume":"61","author":"B Gudbjornsson","year":"2002","unstructured":"Gudbjornsson B, Juliusson UI, Gudbjornsson FV (2002) Prevalence of long-term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 61:32\u201326","journal-title":"Ann Rheum Dis"},{"key":"2964_CR16","first-page":"466","volume":"3","author":"R Mitra","year":"2011","unstructured":"Mitra R (2011) Adverse effects of corticosteroids on bone metabolism: a review. Am J Phy Med Rehabil 3:466\u2013471","journal-title":"Am J Phy Med Rehabil"},{"key":"2964_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"2964_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"FH Holick","year":"2007","unstructured":"Holick FH (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"2964_CR19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.amjmed.2003.12.029","volume":"116","author":"HA Bischoff-Ferrari","year":"2004","unstructured":"Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634\u2013639","journal-title":"Am J Med"},{"key":"2964_CR20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bone.2006.03.009","volume":"39","author":"P D\u2019Amelio","year":"2006","unstructured":"D\u2019Amelio P, Grimaldi A, Bernabei P (2006) Immune system and bone metabolism: does thymectomy influence postmenopausal bone loss in humans? Bone 39:658\u2013665","journal-title":"Bone"},{"key":"2964_CR21","first-page":"1446","volume":"16","author":"HH Ahmed","year":"2012","unstructured":"Ahmed HH, Morcos NYS, Eskander EF, Seoudi DMS, Shalby AB (2012) Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. Eur Rev Med Pharmacol Sci 16:1446\u20131452","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2964_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MNH.0b013e3281ca6ffd","volume":"16","author":"L Shiguang","year":"2007","unstructured":"Shiguang L, Gupta QA, Darryl L (2007) Emerging role of fibroblast growth factor 23 in a bone\u2013kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329\u2013335","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2964_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","volume":"25","author":"H Henneicke","year":"2014","unstructured":"Henneicke H, Gasparini SJ, Brennan-Speranza TC, Zhou H, Seibel MJ (2014) Glucocorticoids and bone: local effects and systemic implications. Trends Endocrinol Metabol 25:197\u2013211","journal-title":"Trends Endocrinol Metabol"},{"key":"2964_CR24","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1074\/jbc.M512624200","volume":"281","author":"Z Yao","year":"2006","unstructured":"Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, Arbini A et al (2006) Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 281:11846\u201311855","journal-title":"J Biol Chem"},{"key":"2964_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bone.2005.06.002","volume":"37","author":"N Franchimont","year":"2005","unstructured":"Franchimont N, Wertz S, Malaise M (2005) Interleukin-6: an osteotropic factor influencing bone formation? Bone 37:601\u2013606","journal-title":"Bone"},{"key":"2964_CR26","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","volume":"145","author":"Y Ishimi","year":"1990","unstructured":"Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y et al (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297\u20133303","journal-title":"J Immunol"},{"key":"2964_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-10-1","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville K (2010) A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 10:1\u20139","journal-title":"BMC Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-2964-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T13:29:35Z","timestamp":1692797375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-2964-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2964"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-2964-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}